Paxman AB
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of … Read more
Market Cap & Net Worth: Paxman AB (PXMBF)
Paxman AB (PINK:PXMBF) has a market capitalization of $81.46 Million ($81.46 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #21294 globally and #7656 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Paxman AB's stock price $3.50 by its total outstanding shares 23273416 (23.27 Million).
Paxman AB Market Cap History: 2019 to 2025
Paxman AB's market capitalization history from 2019 to 2025. Data shows change from $144.06 Million to $81.46 Million (-10.32% CAGR).
Paxman AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Paxman AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.32x
Paxman AB's market cap is 0.32 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.03x
Paxman AB's market cap is 2.03 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $144.06 Million | $85.28 Million | $2.76 Million | 1.69x | 52.27x |
| 2020 | $68.66 Million | $78.05 Million | -$19.19 Million | 0.88x | N/A |
| 2021 | $150.35 Million | $96.20 Million | -$12.78 Million | 1.56x | N/A |
| 2022 | $166.40 Million | $156.75 Million | -$10.32 Million | 1.06x | N/A |
| 2023 | $65.17 Million | $220.61 Million | $8.33 Million | 0.30x | 7.82x |
| 2024 | $81.46 Million | $253.01 Million | $40.20 Million | 0.32x | 2.03x |
Competitor Companies of PXMBF by Market Capitalization
Companies near Paxman AB in the global market cap rankings as of March 18, 2026.
Key companies related to Paxman AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Paxman AB Historical Marketcap From 2019 to 2025
Between 2019 and today, Paxman AB's market cap moved from $144.06 Million to $ 81.46 Million, with a yearly change of -10.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $81.46 Million | 0.00% |
| 2024 | $81.46 Million | +25.00% |
| 2023 | $65.17 Million | -60.84% |
| 2022 | $166.40 Million | +10.68% |
| 2021 | $150.35 Million | +118.98% |
| 2020 | $68.66 Million | -52.34% |
| 2019 | $144.06 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Paxman AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $81.46 Million USD |
| MoneyControl | $81.46 Million USD |
| MarketWatch | $81.46 Million USD |
| marketcap.company | $81.46 Million USD |
| Reuters | $81.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.